(April 2019) – Jennifer Dent sits down with ecancer at the 2019 American Association for Cancer Research (AACR) meeting to discuss how AAI is working to improve cancer patient outcomes in Africa.
April 2019 – Africa’s cancer crisis parallels what the USA faced in the 1950s — when cancer invariably meant death. But unlike the past, we now have the tools and technologies to rewrite the cancer narrative. Through collaborative, multi-sector efforts such as AAI, we can reverse cancer mortality patterns on the African continent and bring hope to patients.
March 2019 – WIPO Re:Search is an innovative and impactful public-private partnership model that promotes cross-sector intellectual property sharing and R&D to accelerate tropical disease drug discovery and development. Importantly, WIPO Re:Search also drives progress toward the United Nations Sustainable Development Goals (SDGs). Through case studies, the article illustrates how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers from academic/non-profit organizations and small companies (including scientists in low- and middle-income countries) to leapfrog their R&D programs by accessing pharmaceutical industry resources that may not otherwise be available to them.
(February 2019) Since WIPO Re:Search’s launch in 2011, the Consortium has grown to 140 member organizations across 40 countries and boasts a portfolio of 140 NTDs, malaria, and TB R&D collaborations .
Read the 2018 Annual report to learn more: https://bit.ly/2EkITDe
January 2019 – Schistosomiasis affects 200+ million people around the world with 700+ million people at risk of contracting the disease. Don’t miss our new publication in The Tropical Medicine and Infectious Disease highlighting the important role
WIPO Re:Search and cross-sector partnerships play in eliminating this disease.
(January 2019) BVGH President Jennifer Dent shares her thoughts on global cancer trends in a new LinkedIn blog post:
(November 2018) Check out BVGH’s STAT News op-ed to find out how providing early access to life-saving cancer drugs in Africa could improve outcomes for patients in the US:
(September 2018) Under the auspices of AAI, the Nigerian Federal Ministry of Health and BVGH will launch a pilot drug access program to combat the growing cancer burden in Nigeria. Plans were finalized at a cancer stakeholder meeting in Abuja.
The Nigerian Federal Ministry of Health will be issuing a Request for Proposals (RFP) to pharmaceutical companies to kick-start the program.
August 2018 – We are excited to announce the release of our WIPO Re:Search Mid-Year Report 2018! Over the first half of the year, BVGH established ten new collaborations and recruited five new Members. Read the Report to learn how the BVGH team is well on its way to achieving and surpassing its goals and deliverables for 2018.